S
Sera Economics
← US Companies

HONEYWELL INTERNATIONAL INC

HON · Nasdaq · CIK 0000773840

SIC 3724

Aircraft Engines & Engine Parts

Category

Transportation Equipment

Entity

operating

Incorp.

DE

Fiscal Y/E

1231

Source: SEC EDGAR · All filings on SEC →

Investment Indicators

$219.13

+6.01 (+2.82%)

Open

$214.87

High

$221.04

Low

$214.87

Prev Close

$213.12

Volume

3,069,391

52W High

$248.18

52W Low

$185.84

50-day MA

$228.75

Quote as of: 2026-05-11

Market Cap

$137.41B

P/E

34.70

P/B

9.77

PEG

1.91

EPS

6.25

BPS

21.45

Dividend Yield

2.22%

Beta

0.81

ROE

34.01%

ROA

6.42%

Current Ratio

1.30

Gross Margin

9.50%

Operating Margin

22.25%

Net Margin

12.95%

Book Value/Share

$21.89

Intrinsic Value Estimates

Multiple valuation methods, each with its own assumptions — outputs can diverge widely

Median consensus (6 methods)

$43.38B

Deep overvalued +216.7%
MethodImplied market capvs current

Graham Number

√(22.5 × 순이익 × 자본)

$38.46B+257%

Graham Formula

순이익 × (8.5 + 2 × 성장률%)

N/A

Justified P/E

순이익 × 산업 평균 P/E

$70.94B+94%

P/B 배수

자본 × 산업 평균 P/B

$20.86B+559%

P/S 배수

매출 × 산업 평균 P/S

$73.06B+88%

DCF (Gordon)

CF × (1+g) / (r − g)

$48.31B+184%

DDM (Gordon)

D × (1+g) / (r − g)

$26.51B+418%
▶ Detailed analysis — formula walk-through & scenarios

Why this conclusion

Of the 7 valuation methods, 6 were applicable. Their median fair-value lands +216.7% below the current market cap → the stock trades above most formulas' estimates (overvalued). 6 methods flag overvalued, 0 flag undervalued, the rest land within fair range. Read each formula's assumptions below before treating any single number as the answer.

Graham Number

Overvalued +257.3%

√(22.5 × 순이익 × 자본)

Current

$137.41B

Implied fair

$38.46B

Gap (current − fair)

+$98.95B(+257.3%)

NetIncome = $4.73B
Equity = $13.90B
√(22.5 × $4.73B × $13.90B) = $38.46B
  • 최대 PER 15배
  • 최대 PBR 1.5배
  • 안정적 흑자 기업 가정 (금융·고성장 부정확)

Graham Formula

순이익 × (8.5 + 2 × 성장률%)

Not applicable: -

Justified P/E

Overvalued +93.7%

순이익 × 산업 평균 P/E

Current

$137.41B

Implied fair

$70.94B

Gap (current − fair)

+$66.48B(+93.7%)

NetIncome = $4.73B
Industry P/E = 15×
$4.73B × 15 = $70.94B
  • 산업 평균 PER 15x 가정 (사용자 정의 가능)
  • 동종 업종 비교가 핵심 — 산업별 평균 P/E 사용 권장

P/B 배수

Overvalued +558.9%

자본 × 산업 평균 P/B

Current

$137.41B

Implied fair

$20.86B

Gap (current − fair)

+$116.56B(+558.9%)

Equity = $13.90B
Industry P/B = 1.5×
$13.90B × 1.5 = $20.86B
  • 산업 평균 PBR 1.5x 가정
  • 은행·보험·자산집약적 산업에 특히 유효

P/S 배수

Overvalued +88.1%

매출 × 산업 평균 P/S

Current

$137.41B

Implied fair

$73.06B

Gap (current − fair)

+$64.36B(+88.1%)

Revenue = $36.53B
Industry P/S = 2×
$36.53B × 2 = $73.06B
  • 산업 평균 PSR 2x 가정
  • 매출 기반 — 적자 기업·신생 기업에 적용 가능
  • 이익률 차이 무시

DCF (Gordon)

Overvalued +184.5%

CF × (1+g) / (r − g)

Current

$137.41B

Implied fair

$48.31B

Gap (current − fair)

+$89.11B(+184.5%)

FCF = $5.42B
Discount r = 4.0% + 5.0% = 9.0%
Growth g = -2.0%
$5.42B × (1 + -2.0%) / (9.0% − -2.0%) = $48.31B
  • 현금흐름 입력: FCF (잉여현금흐름)
  • 할인율 9.0% (무위험 4.0% + 주식위험프리미엄 5.0%)
  • 영구 성장률 -2.0% (실질 GDP 수준)

DDM (Gordon)

Overvalued +418.3%

D × (1+g) / (r − g)

Current

$137.41B

Implied fair

$26.51B

Gap (current − fair)

+$110.90B(+418.3%)

Dividend D = $2.98B
Discount r = 9.0%
Growth g = -2.0%
$2.98B × (1 + -2.0%) / (9.0% − -2.0%) = $26.51B
  • 배당 입력: 실제 지급 배당
  • 할인율 9.0%
  • 배당 영구 성장률 -2.0%

DCF sensitivity: discount rate × terminal growth

Each cell is the (current vs FCF × (1+g) / (r − g)) discount % under the assumed growth g and discount r.

g \ r7%8%9%10%11%
1%+50.6%+75.7%+100.7%+125.8%+150.9%
2%+24.2%+49.1%+73.9%+98.8%+123.6%
3%-1.6%+23.0%+47.6%+72.2%+96.8%
4%-26.9%-2.5%+21.8%+46.2%+70.6%
5%-51.7%-27.6%-3.5%+20.7%+44.8%

DDM sensitivity: discount rate × dividend growth

Each cell is the discount % vs Dividend × (1+g) / (r − g) under the assumed growth g and discount r.

g \ r7%8%9%10%11%
1%+174.3%+220.0%+265.7%+311.5%+357.2%
2%+126.3%+171.6%+216.9%+262.1%+307.4%
3%+79.3%+124.1%+169.0%+213.8%+258.6%
4%+33.2%+77.6%+122.0%+166.4%+210.8%
5%-12.0%+31.9%+75.9%+119.9%+163.9%

All estimates rest on strong assumptions. Treat the spread, not any single number, as the signal.

Financial Statements

In USD millions (per-share figures shown directly) · Financials as of: 2026-02-17

Income Statement

FY20252024202320222020
Cost of Revenue23,61323,83622,99523,82523,394
Gross Profit3,47010,468
Operating Income8,1278,699
Net Income4,7295,7055,6584,9665,542
EPS (Basic)7.408.768.537.338.01
EPS (Diluted)7.368.718.477.277.91

Balance Sheet

FY20252024202320222020
Total Assets73,68175,19661,52562,27564,470
Current Assets30,38727,90823,50224,98225,372
Cash & Equivalents12,48710,5677,9259,62710,959
Current Liabilities23,41421,25618,53919,93819,508
Long-term Debt29,04627,26518,35816,85316,057
Total Equity13,90418,61915,85616,69718,569

Cash Flow

FY20252024202320222020
Operating CF6,4086,0975,3405,2746,038
Investing CF-2,711-10,157-1,293-93-1,061
Financing CF-1,9536,839-5,763-6,330-8,254
CapEx9861,1641,039766895
Dividends Paid2,9762,9022,8552,7192,626

📄 SEC Filings

Other filings (85)
SCHEDULE 13G

SCHEDULE 13G

xslSCHEDULE_13G_X02/primary_doc.xml

2026-04-30

Open →

4

Insider Transaction

FORM 4

2026-04-27

Open →

DEFA14A

DEFA14A

DEFA14A

2026-04-24

Open →

4

Insider Transaction

FORM 4

2026-04-16

Open →

4

Insider Transaction

FORM 4

2026-04-16

Open →

4

Insider Transaction

FORM 4

2026-04-16

Open →

4

Insider Transaction

FORM 4

2026-04-16

Open →

4

Insider Transaction

FORM 4

2026-04-16

Open →

4

Insider Transaction

FORM 4

2026-04-16

Open →

4

Insider Transaction

FORM 4

2026-04-16

Open →

4

Insider Transaction

FORM 4

2026-04-16

Open →

4

Insider Transaction

FORM 4

2026-04-16

Open →

4

Insider Transaction

FORM 4

2026-04-16

Open →

4

Insider Transaction

FORM 4

2026-04-16

Open →

4

Insider Transaction

FORM 4

2026-04-16

Open →

25-NSE

25-NSE

xslF25X02/primary_doc.xml

2026-04-10

Open →

ARS

ARS

ARS

2026-04-10

Open →

DEFA14A

DEFA14A

DEFA14A

2026-04-10

Open →

4

Insider Transaction

FORM 4

2026-04-02

Open →

4

Insider Transaction

FORM 4

2026-04-02

Open →

S-8

S-8

S-8

2026-04-01

Open →

SCHEDULE 13G/A

SCHEDULE 13G/A

xslSCHEDULE_13G_X02/primary_doc.xml

2026-03-27

Open →

PRE 14A

PRE 14A

PRE 14A

2026-03-06

Open →

4

Insider Transaction

FORM 4

2026-03-03

Open →

4

Insider Transaction

FORM 4

2026-03-03

Open →

144

144

xsl144X01/primary_doc.xml

2026-03-02

Open →

144

144

xsl144X01/primary_doc.xml

2026-03-02

Open →

4

Insider Transaction

FORM 4

2026-02-25

Open →

4

Insider Transaction

FORM 4

2026-02-25

Open →

4

Insider Transaction

FORM 4

2026-02-25

Open →

4

Insider Transaction

FORM 4

2026-02-25

Open →

4

Insider Transaction

FORM 4

2026-02-25

Open →

4

Insider Transaction

FORM 4

2026-02-24

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-23

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-23

Open →

4

Insider Transaction

FORM 4

2026-02-20

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-19

Open →

4

Insider Transaction

FORM 4

2026-02-18

Open →

4

Insider Transaction

FORM 4

2026-02-18

Open →

4

Insider Transaction

FORM 4

2026-02-18

Open →

4

Insider Transaction

FORM 4

2026-02-18

Open →

4

Insider Transaction

FORM 4

2026-02-18

Open →

4

Insider Transaction

FORM 4

2026-02-17

Open →

4

Insider Transaction

FORM 4

2026-02-17

Open →

4

Insider Transaction

FORM 4

2026-02-17

Open →

4

Insider Transaction

FORM 4

2026-02-17

Open →

4

Insider Transaction

FORM 4

2026-02-13

Open →

4

Insider Transaction

FORM 4

2026-02-13

Open →

4

Insider Transaction

FORM 4

2026-02-12

Open →

4

Insider Transaction

FORM 4

2026-02-12

Open →

4

Insider Transaction

FORM 4

2026-02-12

Open →

4

Insider Transaction

FORM 4

2026-02-09

Open →

144

144

xsl144X01/primary_doc.xml

2026-02-06

Open →

4

Insider Transaction

FORM 4

2026-02-03

Open →

144

144

xsl144X01/primary_doc.xml

2026-01-30

Open →

4

Insider Transaction

FORM 4

2026-01-06

Open →

4

Insider Transaction

FORM 4

2026-01-06

Open →

4

Insider Transaction

FORM 4

2026-01-06

Open →

4

Insider Transaction

FORM 4

2026-01-06

Open →

4

Insider Transaction

FORM 4

2026-01-06

Open →

4

Insider Transaction

FORM 4

2026-01-06

Open →

4

Insider Transaction

FORM 4

2026-01-06

Open →

4

Insider Transaction

FORM 4

2026-01-06

Open →

4

Insider Transaction

FORM 4

2026-01-06

Open →

4

Insider Transaction

FORM 4

2026-01-06

Open →

4

Insider Transaction

FORM 4

2026-01-06

Open →

4

Insider Transaction

FORM 4

2026-01-05

Open →

3

3

FORM 3

2026-01-05

Open →

4

Insider Transaction

FORM 4

2025-12-18

Open →

4

Insider Transaction

FORM 4

2025-12-17

Open →

4

Insider Transaction

FORM 4

2025-11-05

Open →

3

3

FORM 3

2025-11-05

Open →

4

Insider Transaction

FORM 4

2025-10-30

Open →

4

Insider Transaction

FORM 4

2025-10-30

Open →

4

Insider Transaction

FORM 4

2025-10-29

Open →

144

144

xsl144X01/primary_doc.xml

2025-10-27

Open →